Australia markets close in 19 minutes

Yuyu Pharma, Inc. (000225.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
4,890.000.00 (0.00%)
As of 02:27PM KST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
136,320,344
137,209,589
138,881,056
115,655,485
98,119,846
Cost of revenue
87,151,062
88,312,980
85,567,913
70,320,100
52,850,892
Gross profit
49,169,281
48,896,608
53,313,144
45,335,385
45,268,955
Operating expenses
Research development
-
7,187,636
8,620,374
4,008,281
4,122,659
Selling general and administrative
22,043,649
15,898,981
19,991,958
16,376,184
14,132,447
Total operating expenses
-
48,532,071
53,905,257
44,135,217
38,998,027
Operating income or loss
12,480,860
364,537
-592,113
1,200,168
6,270,928
Interest expense
-
2,553,778
2,580,742
2,175,396
1,758,561
Income before tax
-326,045
-5,442,145
-3,810,377
-383,155
3,711,335
Income tax expense
94,639
98,436
615,016
537,134
1,298,730
Income from continuing operations
-420,684
-5,540,582
-4,425,393
-920,289
2,412,605
Net income
-2,100,544
-7,180,900
-5,987,681
-2,213,800
1,283,521
Net income available to common shareholders
-2,100,544
-7,180,900
-5,987,681
-2,213,800
1,283,521